Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Petros Pharmaceuticals

Market Cap: US$1.1m

A healthcare technology company, focuses on developing and licensing proprietary SaaS platform and Software as a medical device web application designed to assist pharmaceutical companies.

Klotho Neurosciences

Market Cap: US$29.3m

Develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders.

Shamrock Industrial

Market Cap: ₹95.5m

Does not have significant operations.

Metsera

Market Cap: US$5.5b

A clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases.

Adicet Bio

Market Cap: US$69.8m

A clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States.

Mineralys Therapeutics

Market Cap: US$3.1b

A clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.

Bioqual

Market Cap: US$35.8m

Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.

Protalix BioTherapeutics

Market Cap: US$162.7m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

BioMarin Pharmaceutical

Market Cap: US$10.1b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Heidelberg Pharma

Market Cap: €137.0m

A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, the United States, and internationally.

EZZ Life Science Holdings

Market Cap: AU$103.3m

Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia.

Syngene International

Market Cap: ₹242.6b

A contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally.

Shanghai Shenqi Pharmaceutical Investment Management

Market Cap: CN¥3.3b

Operates as a pharmaceutical manufacturing holding investment company in China.

Lin BioScience

Market Cap: NT$13.3b

A drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases.

SYN-TECH Chem. & Pharm

Market Cap: NT$3.3b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.

Great Novel Therapeutics Biotech & Medicals

Market Cap: NT$1.3b

Engages in the development of drugs for the treatment of advanced and refractory cancers.

Amrutanjan Health Care

Market Cap: ₹20.8b

Manufactures, supplies, and sells ayurvedic pain balms and women hygiene products in India and internationally.

Cenra

Market Cap: NT$4.9b

Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.

Ha Tay Pharmaceutical JSC

Market Cap: ₫6.9t

Manufactures, trades in, imports, and exports medicines, chemical raw materials for medicine, medicinal materials, and medical equipment.

Amplia Therapeutics

Market Cap: AU$77.0m

A clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia.

Medigen Biotechnology

Market Cap: NT$4.0b

A biopharmaceutical company, engages in the research and development of new drugs and vaccines, cytotherapy, advanced nucleic acid testing, generic drugs, aesthetic medicine, and vaccine-related products in Taiwan.

Shanghai Shyndec Pharmaceutical

Market Cap: CN¥14.3b

Shanghai Shyndec Pharmaceutical Co., Ltd.

Neurizon Therapeutics

Market Cap: AU$64.0m

A clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases.

Samsrita Labs

Market Cap: ₹433.2m

Operates as a biopharmaceutical company in India.

Daihan PharmaceuticalLtd

Market Cap: ₩175.5b

Engages in the manufacture and sale of therapeutic drugs in South Korea.

Voronoi

Market Cap: ₩2.7t

Researches, develops, and discovers small molecule kinase inhibitors in South Korea.

Orthocell

Market Cap: AU$320.2m

A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia and internationally.

Pak Fah Yeow International

Market Cap: HK$772.9m

An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.

Newland Pharmaceutical

Market Cap: CN¥5.0b

Engages in the research and development, production, and sale of pharmaceutical intermediates and APIs in China.

Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd

Market Cap: HK$8.1b

Engages in the research, development, manufacture, and sale of bio-pharmaceutical products in the People's Republic of China.

Abbott Laboratories (Pakistan)

Market Cap: PK₨124.5b

Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.

Zenotech Laboratories

Market Cap: ₹3.2b

Manufactures and markets pharmaceutical specialty generic injectables in the oncology and anesthesiology markets in India.

Mochida Pharmaceutical

Market Cap: JP¥117.0b

Manufactures and sells pharmaceuticals and healthcare products in Japan.

Zeria Pharmaceutical

Market Cap: JP¥92.7b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.

Immuron

Market Cap: AU$20.4m

A biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada.

Tissue Repair

Market Cap: AU$17.2m

A clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia.